Janus Henderson Group’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $478M | Buy |
14,691,344
+2,925,863
| +25% | +$95.1M | 0.23% | 104 |
|
|
2025
Q1 | $816M | Buy |
11,765,481
+1,190,118
| +11% | +$82.5M | 0.45% | 39 |
|
|
2024
Q4 | $866M | Sell |
10,575,363
-346,533
| -3% | -$28.4M | 0.44% | 38 |
|
|
2024
Q3 | $1.25B | Buy |
10,921,896
+2,052,989
| +23% | +$235M | 0.64% | 21 |
|
|
2024
Q2 | $670M | Buy |
8,868,907
+1,195,039
| +16% | +$90.2M | 0.36% | 57 |
|
|
2024
Q1 | $524M | Buy |
7,673,868
+692,492
| +10% | +$47.3M | 0.29% | 88 |
|
|
2023
Q4 | $438M | Sell |
6,981,376
-79,212
| -1% | -$4.97M | 0.26% | 101 |
|
|
2023
Q3 | $360M | Buy |
7,060,588
+837
| +0% | +$42.7K | 0.24% | 112 |
|
|
2023
Q2 | $353M | Sell |
7,059,751
-67,860
| -1% | -$3.39M | 0.22% | 116 |
|
|
2023
Q1 | $267M | Buy |
7,127,611
+1,153,472
| +19% | +$43.2M | 0.18% | 137 |
|
|
2022
Q4 | $286M | Sell |
5,974,139
-3,101,363
| -34% | -$149M | 0.2% | 125 |
|
|
2022
Q3 | $218M | Buy |
9,075,502
+4,851,015
| +115% | +$116M | 0.08% | 224 |
|
|
2022
Q2 | $91.9M | Sell |
4,224,487
-105,277
| -2% | -$2.29M | 0.06% | 265 |
|
|
2022
Q1 | $105M | Buy |
4,329,764
+83,100
| +2% | +$2.01M | 0.05% | 311 |
|
|
2021
Q4 | $101M | Buy |
4,246,664
+153,198
| +4% | +$3.64M | 0.04% | 354 |
|
|
2021
Q3 | $104M | Sell |
4,093,466
-23,493
| -0.6% | -$596K | 0.05% | 355 |
|
|
2021
Q2 | $92.7M | Sell |
4,116,959
-113,348
| -3% | -$2.55M | 0.04% | 388 |
|
|
2021
Q1 | $83.5M | Buy |
4,230,307
+33,529
| +0.8% | +$662K | 0.04% | 421 |
|
|
2020
Q4 | $108M | Buy |
4,196,778
+349
| +0% | +$8.94K | 0.05% | 340 |
|
|
2020
Q3 | $200M | Sell |
4,196,429
-529,363
| -11% | -$25.2M | 0.1% | 199 |
|
|
2020
Q2 | $140M | Buy |
+4,725,792
| New | +$140M | 0.08% | 249 |
|